Adagene Inc
Biotechnology
Healthcare
ADAG
44.17 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.45
52 week high
3.49
high
1.45
52 week low
1.40
low
1.36
growth
-50.00 %
previous Close
1.45
P/E ratio
market cap
108 M
div yield
0
usd
Sep 2023
qoq
revenue
408 K
-97.64 %
net incoming
-7.42 M
-80.56 %
eps
0.00 %
71.62 %
eps surprise
-10.53 %
net profit margin
-1818.90 %
-1795.00 %
operating incoming
-9.34 M
-10.29 %
net change in cash
0.00 %
cash on hand
110 M
-14.62 %
cost of revenue
0.00 %
top top